Safety and Tolerability Study of Transscleral Iontophoresis by the EyeGate® II Drug Delivery Device System

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Healthy
Interventions
OTHER

EyeGate II® Drug Delivery System

Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

DRUG

Citrate buffer

Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Trial Locations (1)

560 034

St. John's Medical College Hospital, Bangalore

Sponsors
All Listed Sponsors
lead

Eyegate Pharmaceuticals, Inc.

INDUSTRY